US Patent Issued to The United States of America, as represented by the Secretary Department of Health and Human Services on Nov. 4 for "HIV-1 ENV fusion peptide immunogens and their use" (Maryland, District Of Columbia Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,691, issued on Nov. 4, was assigned to The United States of America, as represented by the Secretary Department of Health and Human Services (Bethesda, Md.).

"HIV-1 ENV fusion peptide immunogens and their use" was invented by Peter Kwong (Washington), Rui Kong (Bethesda, Md.), Tongqing Zhou (Boyds, Md.), John Mascola (Rockville, Md.), Kai Xu (Bethesda, Md.), Cheng Cheng (Bethesda, Md.), Gwo-Yu Chuang (Rockville, Md.), Kevin Liu (Bethesda, Md.), Baoshan Zhang (Bethesda, Md.), Li Ou (Potomac, Md.) and Wing-Pui Kong (Germantown, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of immunogens based on the HIV-1 Env fusion peptide and methods...